Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl-L-Leucine for treatment of ataxia-telangiectasia
IRCT20210413050958N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of levacetylleucine in ataxia-telangiectasia (AT), sponsored by Mashhad University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
levacetylleucine
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on IRCT20210413050958N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210413050958N1.